Stocks and Investing Stocks and Investing
Tue, November 23, 2021
Mon, November 22, 2021
Sun, November 21, 2021
Sat, November 20, 2021
Fri, November 19, 2021
Thu, November 18, 2021

Thomas Smith Initiated (VRDN) at Buy and Held Target at $32 on, Nov 18th, 2021


Published on 2024-10-27 18:42:11 - WOPRAI, Thomas Smith
  Print publication without navigation


Thomas Smith of SVB Leerink, Initiated "Viridian Therapeutics, Inc." (VRDN) at Buy and Held Target at $32 on, Nov 18th, 2021.

Thomas has made no other calls on VRDN in the last 4 months.



There are 2 other peers that have a rating on VRDN. Out of the 2 peers that are also analyzing VRDN, 0 agree with Thomas's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Thomas


  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $36 on, Friday, November 5th, 2021
  • Maneka Mirchandaney of "Evercore ISI Group" Initiated at Buy and Held Target at $40 on, Tuesday, October 12th, 2021